Close

Adaptimmune Therapeutics (ADAP) Tops Q2 EPS by 16c

Go back to Adaptimmune Therapeutics (ADAP) Tops Q2 EPS by 16c

Form 8-K Adaptimmune Therapeutics For: Aug 03

August 4, 2016 6:05 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

... More